BioMarin to Host 2024 Investor Day on September 4th in New York
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) has announced its upcoming Investor Day scheduled for September 4, 2024, in New York City. The event, running from 10:30 am to 1:00 pm Eastern Time, will be accessible via live webcast. Key highlights include:
- Presentations from executive management team
- Focus on BioMarin's pipeline and strategic plans
- Insights into growth opportunities
- Discussion of long-term financial outlook
Investors and analysts can access the webcast and presentation materials through the company's investor relations website. A replay will be available shortly after the event concludes, providing an opportunity for those unable to attend live to catch up on the important updates shared during the Investor Day.
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) ha annunciato il suo prossimo Investor Day fissato per il 4 settembre 2024, a New York City. L'evento, che si svolgerà dalle 10:30 alle 13:00 ora orientale, sarà accessibile tramite webcast dal vivo. I punti salienti includono:
- Presentazioni dal team di gestione esecutiva
- Focus sul pipeline di BioMarin e sui piani strategici
- Approfondimenti sulle opportunità di crescita
- Discussione delle prospettive finanziarie a lungo termine
Investitori e analisti possono accedere al webcast e ai materiali di presentazione attraverso il sito web di relazioni con gli investitori della società. Una registrazione sarà disponibile poco dopo la conclusione dell'evento, offrendo un'opportunità a coloro che non possono partecipare dal vivo di recuperare gli aggiornamenti importanti condivisi durante l'Investor Day.
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) ha anunciado su próximo Día del Inversor programado para el 4 de septiembre de 2024, en la ciudad de Nueva York. El evento, que se llevará a cabo de 10:30 a 13:00 hora del Este, será accesible a través de webcast en vivo. Los aspectos destacados incluyen:
- Presentaciones del equipo de gestión ejecutiva
- Enfoque en el pipeline de BioMarin y sus planes estratégicos
- Perspectivas sobre oportunidades de crecimiento
- Discusión del panorama financiero a largo plazo
Los inversores y analistas podrán acceder al webcast y a los materiales de presentación a través del sitio web de relaciones con inversores de la empresa. Una repetición estará disponible poco después de la conclusión del evento, brindando la oportunidad a quienes no puedan asistir en vivo de ponerse al día con las actualizaciones importantes compartidas durante el Día del Inversor.
바이오마린 제약 주식회사(BioMarin Pharmaceutical Inc., NASDAQ: BMRN)가 뉴욕시에서 투자자 날을 2024년 9월 4일로 예정하고 있다고 발표했습니다. 이 행사는 동부 표준시 기준으로 오전 10:30부터 오후 1:00까지 진행되며, 실시간 웹캐스트를 통해 접근할 수 있습니다. 주요 하이라이트는 다음과 같습니다:
- 경영진 팀의 프레젠테이션
- 바이오마린의 파이프라인과 전략적 계획에 대한 집중
- 성장 기회에 대한 통찰력
- 장기 재무 전망에 대한 논의
투자자와 애널리스트는 회사의 투자자 관계 웹사이트를 통해 웹캐스트와 프레젠테이션 자료에 접근할 수 있습니다. 이벤트가 종료된 후 곧바로 재생이 가능하여, 실시간 참석이 불가능한 분들이 투자자 날에 공유된 중요한 업데이트를 확인할 수 있는 기회를 제공합니다.
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) a annoncé son prochain Jour Investisseur programmé pour le 4 septembre 2024, à New York. L'événement, qui se déroulera de 10h30 à 13h00, heure de l'Est, sera accessible via webcast en direct. Les points forts incluent:
- Présentation de l'équipe de direction
- Concentration sur le pipeline de BioMarin et ses plans stratégiques
- Perspectives de croissance
- Discussion sur les perspectives financières à long terme
Les investisseurs et les analystes peuvent accéder au webcast et aux documents de présentation via le site internet des relations investisseurs de l'entreprise. Une rediffusion sera disponible peu après la fin de l'événement, offrant une opportunité pour ceux qui n'ont pas pu participer en direct de se mettre à jour sur les informations importantes partagées lors du Jour Investisseur.
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) hat seinen bevorstehenden Investor Day für den 4. September 2024 in New York City angekündigt. Die Veranstaltung findet von 10:30 bis 13:00 Uhr Eastern Time statt und wird über Live-Webcast zugänglich sein. Zu den wichtigsten Highlights gehören:
- Präsentationen des Management-Teams
- Fokus auf BioMarins Pipeline und strategische Pläne
- Einblicke in Wachstumschancen
- Diskussion der langfristigen Finanzprognosen
Investoren und Analysten können über die Website für Investor Relations des Unternehmens auf den Webcast und die Präsentationsmaterialien zugreifen. Eine Aufzeichnung wird kurz nach Abschluss der Veranstaltung verfügbar sein, sodass diejenigen, die nicht live teilnehmen konnten, die wichtigsten Aktualisierungen nachholen können, die während des Investor Day geteilt wurden.
- None.
- None.
-Event to be webcast live and a replay will be available
BioMarin will host a live webcast on Wednesday, September 4, 2024, at approximately 10:30 am Eastern Daylight Time. Presentation materials will also be available at investors.biomarin.com. A replay of the webcast will be available online shortly after the live webcast is completed.
About BioMarin
Founded in 1997, BioMarin is a global biotechnology Company dedicated to transforming lives through genetic discovery. The Company develops and commercializes targeted therapies that address the root cause of genetic conditions. BioMarin's unparalleled research and development capabilities have resulted in eight transformational commercial therapies for patients with rare genetic disorders. The Company's distinctive approach to drug discovery has produced a diverse pipeline of commercial, clinical, and pre-clinical candidates that address a significant unmet medical need, have well-understood biology, and provide an opportunity to be first-to-market or offer a substantial benefit over existing treatment options. For additional information, please visit www.biomarin.com.
Contacts: | |
Investors | Media |
Traci McCarty | Marni Kottle |
BioMarin Pharmaceutical Inc. | BioMarin Pharmaceutical Inc. |
(415) 455-7558 | (650) 374-2803 |
View original content to download multimedia:https://www.prnewswire.com/news-releases/biomarin-to-host-2024-investor-day-on-september-4th-in-new-york-302224592.html
SOURCE BioMarin Pharmaceutical Inc.
FAQ
When is BioMarin's 2024 Investor Day?
Will BioMarin's Investor Day be available online?
What topics will be covered at BioMarin's 2024 Investor Day?
How can investors access BioMarin's Investor Day materials?
